Hinge Health, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-87.3% vs price
Base Case (Median)
-77.0% vs price
Bull Case (75th pct.)
-54.9% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $9.40 | -89.3% | High (40%) |
| PE Comparable | $28.71 | -67.3% | Medium (25%) |
| Graham Number | $11.78 | -86.6% | Medium (40%) |
| EV/FCF | $72.57 | -17.4% | Medium (20%) |
Based on 4 out of 8 methods, HNGE appears overvalued at the current price of $87.87. The base case fair value of $20.24 implies 77.0% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.